Thomas Graeser

No ORCID on file · 4 papers in corpus
rct 2007
A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women
Maturitas ·doi:10.1016/j.maturitas.2007.08.004

OBJECTIVES: To evaluate the effects of an estrogen-reduced, continuous-combined hormone therapy preparation (HT) containing 1mg estradiol valerate (1EV) and 2mg dienogest (2DNG) on the number of moderate and severe hot flushes. METHODS: Th…

rct 2007
A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625180701441030

OBJECTIVES: To evaluate the impact of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate (1EV) and 2 mg dienogest (2DNG) on metabolism. METHODS: In a randomized double-blin…

1998
P-82. The New Progestin Dienogest in a Continuous-Combined Regimen for HRT
·doi:10.1097/00042192-199805040-00133
1996
Dose-finding Study with the New Progestin Dienogest. Continuous Combined with Estradiol
·doi:10.1097/00042192-199603040-00080

Mueck, A O M.D., Ph.D.; Graeser, T M.D.2; Mellinger, U Ph.D.2; Mueller, A Ph.D.2; Seeger, H Ph.D.1; Oettel, M M.D.2; Lippert, T H M.D.1 Author Information